Adicet Bio, Inc. Marketable Securities
Adicet Bio, Inc. (ACET) had Marketable Securities of $0 as of 2023-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2025-03-06
- 2023-12-31: Marketable Securities $0.00.
- 2021-12-31: Marketable Securities $0.00.
- 2021-09-30: Marketable Securities $0.00.
- 2021-06-30: Marketable Securities $0.00.
| Period end | Marketable Securities |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-10 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-12 |
| 2021-03-31 | $1.75M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $10.28M 10-K · filed 2022-03-15 |
| 2020-09-30 | $23.16M 10-Q · filed 2020-11-05 |
| 2019-12-31 | $62.38M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |